Efficacy of Add-on Montelukast in Nonasthmatic Eosinophilic Bronchitis: The Additive Effect on Airway Inflammation, Cough and Life Quality

BACKGROUND: The efficacy of montelukast (MONT), a cysteinyl leukotriene receptor antagonist, in nonasthmatic eosinophilic bronchitis (NAEB), especially its influence on cough associated life quality is still indefinite. We evaluated the efficacy of MONT combined with budesonide (BUD) as compared to...

Descripción completa

Detalles Bibliográficos
Autores principales: Bao, Wuping, Liu, Ping, Qiu, Zhongmin, Yu, Li, Hang, Jingqing, Gao, Xiaohua, Zhou, Xin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2015
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4837817/
https://www.ncbi.nlm.nih.gov/pubmed/25563311
http://dx.doi.org/10.4103/0366-6999.147805

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4837817/
https://www.ncbi.nlm.nih.gov/pubmed/25563311
http://dx.doi.org/10.4103/0366-6999.147805

Ejemplares similares